Pelage Pharmaceuticals has secured $120 million in Series B financing, co-led by ARCH Venture Partners and GV (Google Ventures), to advance regenerative treatments for hair loss.
Amount Raised
$120 Million
Round Type
Series B
Los AngelesBiotechnologyHealthcareInvestors
Description
Pelage Pharmaceuticals has announced the close of a $120 million Series B financing to support the continued advancement of PP405, a topical therapy for hair loss. The financing was co-led by ARCH Venture Partners and GV, with participation from other investors. Positive Phase 2a results in androgenetic alopecia support progression into Phase 3 trials in 2026. Cathy Friedman of GV and Richard Heyman of ARCH join the Board of Directors.
Quick answer
Pelage Pharmaceuticals raised $120 Million in a Series B round, dated October 15, 2025. Investors: Main Street Advisors, Visionary Ventures, YK Bioventures, ARCH Venture Partners and GV. Pelage Pharmaceuticals is based in Los Angeles, California, United States.
- How much did Pelage Pharmaceuticals raise?
- Pelage Pharmaceuticals raised $120 Million in a Series B round on October 15, 2025.
- Who invested in Pelage Pharmaceuticals?
- Main Street Advisors, Visionary Ventures, YK Bioventures, ARCH Venture Partners and GV are named as investors in this round.
- What does Pelage Pharmaceuticals do?
- Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing first-in-class treatments for hair loss.
- Where is Pelage Pharmaceuticals based and how big is it?
- Pelage Pharmaceuticals is based in Los Angeles, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at Pelage Pharmaceuticals?
- Fundz holds 1 contact at Pelage Pharmaceuticals, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Pelage Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
- Verrica raised $50M on November 25, 2025.
- BlossomHill Therapeutics raised $84M on November 25, 2025.
- MindImmune Therapeutics raised $10M (Series A) on November 24, 2025.
- NEXTSTEP ROBOTICS raised $1M on November 24, 2025.
- ClearPoint Neuro raised $18M on November 20, 2025.
Who to call at Pelage Pharmaceuticals, and when
A new round usually means Pelage Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pelage Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pelage Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pelage Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pelage Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPelage Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.